SLC2A1 and non-small cell lung carcinoma: Therefore, herein, we evaluated 18-F-FDG PET-CT, GLUT1 expression, NLR, PLR, and LMR, among other indicators of tumor metabolic activity and systemic inflammation, for their association with NSCLC and compared their prognostic values.